This site uses cookies to measure how you use the website so it can be updated and improved based on your needs and also uses cookies to help remember the notifications you’ve seen, like this one, so that we don’t show them to you again. If you could also tell us a little bit about yourself, this information will help us understand how we can support you better and make this site even easier for you to use and navigate.

Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer’s disease


Kume, Kazumasa, Hanyu, Haruo, Sakurai, Hirofumi, Takada, Yusuke, Onuma, Takeshi, Iwamoto, Toshihiko


Geriatrics & Gerontology International, Volume: 12, No.: 2, Pages.: 207-214

Year of Publication



Aim: Recent studies have shown that some antihypertensive medications are associated with a significant reduction in the incidence of Alzheimer’s disease (AD). However, it remains uncertain whether antihypertensive drugs may have a preventive effect on cognitive decline in patients with AD. We investigated the effects of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor γ-stimulating activity, on cognition and regional cerebral blood flow (rCBF) in elderly hypertensive patients with AD.; Methods: A total of 20 patients with probable AD and essential hypertension were randomly assigned to the telmisartan group (n = 10, 40-80 mg daily) or the amlodipine group (n = 10, 5-10 mg daily) for 6 months.; Results: The groups had a similar significant reduction in systolic and diastolic blood pressure after treatment. The telmisartan group did not show any changes in cognitive function test scores, while the amlodipine group showed significantly higher scores on the AD Assessment Scale-Cognitive Subscale (Japanese version). Analysis of covariance to analyze treatment effect revealed that the telmisartan group showed increased rCBF in the right supramarginal gyrus, superior parietal lobule, cuneus, and lingual gyrus compared with the amlodipine group, while the amlodipine group showed increased rCBF only in the right cingulate gyrus compared with the telmisartan group at 6 months.; Conclusion: These findings suggest that telmisartan may have additional benefits and be useful for the treatment of elderly hypertensive patients with AD.; © 2011 Japan Geriatrics Society.

Bibtex Citation

@article{Kume_2011, doi = {10.1111/j.1447-0594.2011.00746.x}, url = {}, year = 2011, month = {sep}, publisher = {Wiley-Blackwell}, volume = {12}, number = {2}, pages = {207--214}, author = {Kazumasa Kume and Haruo Hanyu and Hirofumi Sakurai and Yusuke Takada and Takeshi Onuma and Toshihiko Iwamoto}, title = {Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer{textquotesingle}s disease}, journal = {Geriatrics {&} Gerontology International} }


aged, alzheimer disease, angiotensin ii type 1 receptor blockers, benzimidazoles, benzoates, blood, blood supply, brain, cerebral, cerebrovascular circulation, cognition, complications, drug effects, drug therapy, female, flow, humans, hypertension, male, pharmacology, physiopathology, prospective studies, regional blood flow, singleblind method, telmisartan, therapeutic use

Countries of Study


Types of Dementia

Alzheimer’s Disease

Types of Study

Case Control Study

Type of Outcomes

Cognition, Other

Type of Interventions

Pharmaceutical Interventions

Pharmaceutical Interventions